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Two structurally different acylphosphatases found in horse brain were purified; they were not immunologically related. 
The molecular masses were almost identical and the kinetic parameters were rather similar. The data reported indicate 
that one of the purified brain acylphosphatases and an enzyme, previously isolated from horse muscle, are the same pro- 
tein. The presence of this acylphosphatase form in the brain has not been reported before. The other acylphosphatase 
seemed to be the same as the enzyme which had been purified from calf brain and partially characterized by Diederich 
and Grisolia [(1969) J. Biol. Chem. 244,2412-24171. Furthermore, this enzyme seems to be identical to the acylphosphat- 
ase recently purified in our laboratory from human erythrocytes. 
Acylphosphatase; Isoenzyme; Acyl phosphate; (Brain) 
1. INTRODUCTION 
We have previously reported on the existence of 
two distinct but related genes for acylphosphatase 
in human tissues [ 11. Two acylphosphatase isoen- 
zymes, one from skeletal muscle [2,3] and the 
other from erythrocytes [4], were isolated and their 
amino acid sequences determined [5]. About 56% 
of the amino acid positions of these enzymes were 
shown to be homologous. However, differences 
were found in the K,,, and Ki values for some 
substrates and inhibitors [4]. The exact 
physiological significance of the two isoenzymes is 
not yet completely understood. 
Acylphosphatase activity is present in brain ex- 
tracts. Diederich and Grisolia [6] isolated an 
Correspondence address: G. Ramponi, Department of 
Biochemistry, V. le Morgagni 50, 50100 Florence, Italy 2. EXPERIMENTAL 
Abbreviations: HPLC, high-pressure liquid chromatography; CNBr-activated Sepharose 4B was purchased from Phar- 
HBrI, horse brain acylphosphatase, muscular-type isoenzyme; macia, trypsin from Sigma, acetonitrile lichrosolv from Merck 
HBrII, horse brain acylphosphatase, erythrocyte-type isoen- (Darmstadt), and nitrocellulose sheets from LKB. Benzoyl 
zyme; Hoi, ho&e muscle acylphosphatase, mixed disulfide with phosphate was synthesized according to Camici et al. [7]. Anti- 
glutathione form; Ho3, horse muscle acylphosphatase, S-S horse muscle acylphosphatase antibodies were obtained and 
dimer; Mes, 2-N-morpholinoethanesulfonic acid; TFA, purified according to Berti et al. [S]; the immunoadsorbent used 
trifluoroacetic acid; PAGE, polyacrylamide gel electrophoresis in the enzyme purification was prepared according to [3]. Anti- 
acylphosphatase from calf brain whose molecular 
mass, COOH-terminal residues and amino acid 
composition were similar to those of the human 
erythrocyte enzyme and different (except as 
regards molecular mass) from those of the skeletal 
muscle enzyme. 
We investigated the possibility of the presence of 
both enzyme forms in horse brain. The confirma- 
tion of this point could raise other questions. 
Although apparently similar as regards substrate 
specificity and type of reaction catalyzed, as well 
as being evolutionarily related, they might perform 
different functions. Therefore, we decided to 
verify whether horse brain and erythrocyte 
acylphosphatase were identical and if the muscular 
form of acylphosphatase was also expressed in 
horse brain. 
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Fig. 1. (a) Affinity chromatography of the horse brain extract after isoelectric precipitation at pH 7.2. (A) 1 .O M NaCl wash, (B) 0.9% 
NaCl wash, (C) elution with 0.3 N acetic acid. (b) Elution pattern of Sephadex G-75M chromatography of the acylphosphatase activity 
after the affinity chromatography step. Column size, 2.5 x 55 cm; flow rate, 20 ml/h; elution, 0.05 N acetic acid/O. 1 M NaCl; fraction 
volume, 2.5 ml. (-) Relative absorbance at 280 nm; (o---o) acylphosphatase activity. (c) HPLC purification of acylphosphatase 
activity eluted in Sephadex G-75M chromatography. Column, TSK CM 35W (LKB) (7.5 x 150 mm); elution, non-linear NaCl gradient 
(O-O.5 M) in 50 mM Mes-NaOH buffer, pH 6.5; flow rate, 48 ml/h. Arrows indicate the fractions containing acylphosphatase activity. 
(-) Relative absorbance at 280 nm; (-----) NaCl gradient. 
human erythrocyte acylphosphatase antibodies were obtained 
and purified as in [9], using the enzyme which had been purified 
according to Liguri et al. [4] as antigen. Affinity-purified goat 
anti-rabbit horseradish-conjugated antibodies and peroxidase 
color development reagent (containing 4-chloro-1-naphthol) 
were purchased from Bio-Rad. All other reagents were of 
analytical grade or the best commercially available. 
Acylphosphatase activity was checked by a continuous op- 
tical test at 283 nm [lo]; protein concentration was determined 
by the biuret method, by ultraviolet absorption, or by amino 
acid analysis. SDS-PAGE was performed as reported [3]. The 
purity of the enzymes was checked by urea-acetic acid elec- 
trophoresis [ 111. T’ryptic hydrolysis was performed as reported 
in [3]. Tryptic peptides were separated by reverse-phase HPLC 
as in [3] except that the dry hydrolysate was dissolved in 5% 
TFA in water before injection into the column. Amino acid 
analysis was performed according to [3]. 
The agarose gels for double immunodiffusion were cast on 
microscope slides using 2.5 ml of a 1.0% agarose solution in 
Tris-buffered normal saline (pH 7.2). 2-mm diameter wells were 
cut into the gel; each well was filled with 6.0 pl of either the en- 
zyme or the antibody solutions: diffusion was carried out over- 
night at room temperature. Trans-blots to nitrocellulose paper, 
after urea-acetic acid electrophoresis of the enzymes, were per- 
formed in 0.7 N acetic acid at 160 mA constant current for 16 h 
at 4”C, using a Bio-Rad transblot apparatus. After blotting, the 
nitrocellulose sheets were saturated with 3.0% bovine serum 
albumin in 10.0% horse serum for 1 h, washed in 10 mM 
phosphate buffer (pH 7.4) containing 0.9% NaCl and 0.3% 
Tween 20 and incubated overnight in the same buffer in the 
presence of appropriate dilutions of antibody or antiserum. The 
sheets were then washed 3 times in the same buffer for an 
overall period of 30 min and exposed to an appropriate solution 
of horseradish peroxidase-labeled anti-rabbit antibodies diluted 
in the same buffer. The sheets were washed again as above in- 
dicated and exposed to horseradish peroxidase color develop- 
ment solution. 
3. RESULTS 
Acylphosphatase activity was extracted from 
horse brain as reported [6], the only difference in 
the procedure being the use of 2 kg tissue. We 
followed this purification procedure up to the step 
named fraction 2. The pH of fraction 2 was ad- 
justed to 7.2 and the solution was centrifuged at 
34000 x g for 60 min. The supernatant was ap- 
plied to a column (2.5 x 15 cm) containing 
purified anti-horse muscle acylphosphatase an- 
tibodies bound to Sepharose 4B. Only about half 
of the acylphosphatase activity present in the 
supernatant was retained by the immunoadsor- 
bent. This solution was kept apart for successive 
purification of the unbound activity. Al1 suc- 
ceeding operations were according to [3] with 
minor modifications. 
Fig.1 shows the pattern of chromatographic 
steps of enzyme purification. Table 1 summarizes 
the main parameters of the HBrI purification 
steps. 
Table 1 
Purification of horse brain acylphosphatase immunobound form (HBrl)” 
Step Volume Total Total Spec. Purifica- Yield 
(ml) activityb protein act. tion (070) 
(mg) (U/mg) (-fold) 
Extract supernatant 4900 53900 18 130 3.0 1.0 100.0 
Isoelectric precipitation, 
pH 7.2 476 29036 4379 6.6 2.2 53.9 
Affinity chromatography 60 9900 8.88 1115 371.6 18.4 
Gel-filtration on 
Sephadex G-75 156 9360 2.50 3744 1300.0 17.4 
a Starting from about 2 kg tissue 
’ Determined according to Manao et al. [3] 
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Fig.2. (a) CM Sephadex C25 chromatography of non-immunobound acylphosphatase activity. Column size, 2.5 x 25 cm; elution, 
linear NaCl gradient (O-O.5 M) in 20 mM acetate buffer, pH 5.8. (-) Relative absorbance at 280 nm; (-----) acylphosphatase 
activity. (b) HPLC purification of acylphosphatase activity eluted from ion-exchange chromatography. Column, TSK CM 35W (LKB) 
(7.5 x 150 mm); elution, non-linear NaCl gradient (O-O.5 M) in 50 mM Mes-NaOH buffer, pH 6.5. Arrows indicate the fractions 
collected. (--) Relative absorbance at 280 nm; ( o----o) NaCl gradient. (c) Elution pattern of Sephadex G-75M chromatography of 
pooled fractions from HPLC chromatography. Column size, 2.5 x 60 cm; fraction volume, 2.5 ml. (- .-. -) Relative absorbance at 
280 nm; (-----) acylphosphatase activity. The arrows indicate collected fractions. (d) HPLC purification by reverse-phase 
chromatography of material obtained from G-75 M chromatography. Column, Aquapore RP300 (250 x 4.6 mm, IO rm). Solvent A: 
10 mM TFA in water; solvent B: 10 mM TFA in acetonitrile. Flow rate: 1.5 ml/min. (-) Relative absorbance at 280 nm; (-----) 
acetonitrile concentration in effluent. 
The supernatant, containing the acylphosphat- on a (2.5 x 25 cm) CM-Sephadex C25 column in 
ase activity not bound by the immunoaffinity 20 mM acetate buffer; the column was eluted with 
column, was applied once again to the immunoad- an NaCl linear gradient (O-O.5 M in the same buf- 
sorbent to free it completely of HBrI. The solution fer) at a flow rate of 50 ml/h (fig.2a). Fractions 
was then adjusted to pH 5.8 and chromatographed containing acylphosphatase activity, equilibrated 
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Table 2 
Physicochemical data of horse brain acylphosphatases, as compared with those relative to the 
enzymes from horse muscle and human erythrocytes 
HBrl HBrll Hol” HOBO Human 
Low High 
erythro- 
molecular molecular 
cytesb 
mass mass 
pH optimum 
K,,, (benzoyl phosphate) 
(mM) 
Ki (4) (mM) 
Inhibition type 
Ki (Cl-) (mM) 
Inhibition type 
Molecular mass (kDa) 
5.3 5.3 
0.95 1.11 
0.98 0.84 
camp. camp. 
35.0 38.0 
camp. camp. 
12.6 25.1 
6.0 5.5 
0.14 2.00 
0.10 1.70 
camp. camp. 
45.0 41 .o 
camp. camp. 
12.5 12.6 
5.3 5.5 
1.10 0.08 
1.60 0.30 
camp. camp. 
25.0 51.7 
camp. camp. 
24.2 11.5 
a From Manao et al. [3] 
b From Liguri et al. [4] 
camp., competitive 
with 50 mM Mes-NaOH buffer (pH 6.5), were ap- 
plied to a (7.5 x 150 mm) HPLC TSK CM 35W 
column (LKB), and eluted with an NaCl gradient 
in the same buffer, as indicated in fig.2b. Fractions 
containing the enzyme activity were concentrated 
and chromatographed on a (2.5 x 60 cm) Se- 
phadex G-75 M column in 0.05 N acetic acid/ 
0.1 M NaCl at a flow rate of 20 ml/h (fig.2c). The 
pool of fractions containing acylphosphatase ac- 
tivity was chromatographed on an Aquapore 
RP300 HPLC column (10 ,um, 0.46 x 25 cm); the 
column was eluted with a 0.01 M TFA/acetonitrile 
linear gradient at a flow rate of 90 ml/h (fig.2d). 
Urea-acetic acid-PAGE of the enzymes purified 
according to the two procedures above demon- 
strated that HBrI and HBrII were essentially pure 
(not shown). SDS-PAGE of the purified enzymes 
revealed the presence of two molecular forms of 
HBrI, with different apparent molecular masses 
(12.6 and 25.1 kDa, respectively) (not shown). In 
addition, the higher molecular mass band disap- 
peared upon incubation of samples with 2-mer- 
captoethanol, giving rise to a band of molecular 
mass identical to that of the lower molecular mass 
component (as in the case of horse muscle acyl- 
phosphatase [3]). As for HBrII, an apparent 
molecular mass of about 12.6 kDa was calculated 
by SDS-PAGE. Table 2 compares the molecular 
masses and some kinetic parameters of HBrI and 
HBrII, with those previously determined for the 
horse muscle and human erythrocyte acylphos- 
Fig.3. (A,B) lmmunoblot analysis of HBrl and HBrll. (1) 
HBrl, (2) horse muscle acylphosphatase, (3) HBrll, (4) human 
erythrocyte acylphosphatase. The nitrocellulose sheets were 
incubated with anti-horse muscle acylphosphatase purified 
antibodies (A) or anti-human erythrocyte acylphosphatase 
antiserum (B). (C,D) Double immunodiffusion of HBrl (lower 
molecular mass form) and HBrll, in the presence of either 
human erythrocyte (C) or horse muscle acylphosphatase (D). 
(C) Well I, HBrl; well 2, human erythrocyte acylphosphatase; 
well 3, HBrll; well 4, anti-human erythrocyte acylphosphatase 
antiserum. (D) Well 1, HBrl; well 2, horse muscle 
acylphosphatase; well 3, HBrll; well 4, anti-horse muscle 
acylphosphatase purified antibodies. 
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Table 3 
Amino acid analysis of horse brain acylphosphatase? 
Brain Horseb HumanC Calfl 
muscle erythro- brain 
Immuno- Non- cytes 
bound immuno- 
form bound 
(HBrI) form 
(HBrII) 
Aspartic acid 8.6 9.6 8 IO 9.5 
Threonine 6.0 5.2 6 5 6.2 
Serine 12.4 6.1 13 5 5.3 
Glutamic acid 10.4 13.5 10 14 15.0 
Proline 2.8 2.2 3 2 4.0 
Glycine 8.3 9.4 8 10 10.0 
Alanine 3.5 5.0 3 3 5.0 
Cysteine l.Ie 0.7e 1 
Valine 11.2 9.1 I2 9 9.5 
Methionine 1.8 1.2 2 1 I.4 
Isoleucine 3.0 5.5 3 6 4.5 
Leucine 3.4 6.1 3 6 6.8 
Tyrosine 3.1 2.8 4 2 3.0 
Phenylalanine 4.0 4.8 4 5 4.9 
Lysine 9.0 9.8 9 10 9.7 
Histidine 2.0 3 3.0 
Arginine 6.5 4.5 7 4 3.1 
Tryptophan’ I.8 I.3 2 2 2.1 
a Calculated as mol residue/m01 enzyme 
b Residues present in the main chain of horse muscle acylphosphatase 
according to its amino acid sequence [5] 
’ Residues present in the human erythrocyte acylphosphatase according to 
its amino acid sequence [4] 
d Recalculated from data reported by Diederich and Grisolia [6] 
’ Determined as cysteic acid 
r Determined according to Edelhoch 1131 
phatases. The low and high molecular mass forms 
of HBrI showed kinetic parameters which were 
very similar to those calculated for the two enzyme 
forms previously purified from horse skeletal mus- 
cle [3]. On the other hand, the kinetic parameters 
of HBrII appeared quite different from those of 
HBrI but similar to those elicited by the human 
erythrocyte acylphosphatase. 
Fig.3A and B shows the immunoblot analysis of 
HBrI and HBrII as compared with horse muscle 
and human erythrocyte acylphosphatase. The 
sheets were incubated with either purified anti- 
horse muscle acylphosphatase antibodies (A) or 
anti-human erythrocyte acylphosphatase an- 
tiserum (B). At high levels of sensitivity, the im- 
munoblot shows a cross-reaction between 
anti-horse muscle acylphosphatase antibodies and 
HBrI (A) and between anti-human erythrocyte en- 
zyme antiserum and HBrII (B). Fig.3C and D 
shows double immunodiffusion of HBrI (lower 
molecular mass form) and HBrII, respectively, in 
the presence of either anti-human erythrocyte 
acylphosphatase antiserum or anti-horse muscle 
acylphosphatase purified antibodies. In fig.3C a 
reaction of partial identity between HBrII and 
human erythrocyte acylphosphatase is observed in 
the presence of anti-erythrocyte acylphosphatase 
antiserum. Differences in one or more epitopes of 
Fig.4. HPLC-reverse phase separation of tryptic peptides from horse muscle (A) and horse brain (HBrI, lower molecular mass form) 
(B) acylphosphatase. Column and elution conditions were as reported in the legend to fig.3. 
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the two enzymes, probably due to species dif- 
ferences, allowed for the formation of a spur. 
HBrI did not react with the anti-human erythro- 
cyte antiserum. In fig.3D, HBrI and horse muscle 
acylphospatase are not distinguished by anti-horse 
muscle acylphosphatase purified antibodies. In 
fact, a reaction of immunological identity can be 
seen. On the other hand, HBrII did not react with 
these antibodies. Fig.3C and D shows the im- 
munoblot analysis of HBrI and HBrII as com- 
pared with horse muscle and human erythrocyte 
acylphosphatase, which had been incubated with 
either purified anti-horse muscle acylphosphatase 
antibodies or anti-human erythrocyte acylphos- 
phatase antiserum. 
Table 3 lists the amino acid compositions of 
HBrI (lower molecular mass form) and HBrII as 
compared with that of horse skeletal muscle 
acylphosphatase. In addition, table 3 reports on 
the amino acid content of human erythrocyte 
acylphosphatase taken from sequence data [4,5]. 
The amino acid composition of HBrI was almost 
the same as that resulting from the sequence of the 
carboxymethylated derivative of horse skeletal 
muscle acylphosphatase [5]. The amino acid com- 
positon of HBrII was similar to that determined 
for both the human erythrocyte and the bovine 
brain enzymes previously isolated [4,6]. 
The fingerprints of the tryptic peptides of horse 
skeletal muscle acylphosphatase and HBrI (lower 
molecular mass form), performed as indicated 
above, showed two profiles which were very 
similar (fig.4). The amino acid compositions of the 
corresponding peaks (not reported) were almost 
identical. 
4. DISCUSSION 
The data reported demonstrate the existence of 
at least two acylphosphatases in horse brain. The 
calf brain acylphosphatase which had been 
previously isolated [6] is probably one of these en- 
zymes , as there is great similarity between its 
amino acid composition and that of HBrII. The 
two amino acid compositions are also very similar 
to that determined for the acylphosphatase recent- 
ly isolated from human erythrocytes and se- 
quenced in our laboratory [4]: the few differences 
in amino acid composition may be due to species 
difference. The kinetic parameters of the ery- 
216 
throcyte acylphosphatase are very similar to those 
determined for HBrII, further confirming the close 
similarity of these enzymes [4]. 
Our results indicate the presence of an 
acylphosphatase not previously described in horse 
brain. It differs from HBrII and erythrocyte 
acylphosphatase in amino acid composition, im- 
munological behavior, and kinetic parameters. 
Our data on the molecular features, as well as on 
the kinetic and immunological properties of this 
enzyme indicate that it is the acylphosphatase 
previously purified from horse skeletal muscle [3]. 
Finally, our results show that the products of the 
genes for the two acylphosphatase isoenzymes can 
be present at the same time and almost to the same 
extent in total brain. 
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